investors await final word from the FDA for approval of Onsolis
The fact that the FDA informed Biodelivery that a decision is close and an extension letter would not be needed is a positive sign, in my opinion. With the BDSI stock price slowly inching up over the past few months chances of an Onsolis approval are good.
| Price | $3.52 |
| Price change for today in $ | +$0.04 |
| Price change for today in % | +1.24% |
| P&P rating | ![]() |
| Open Price | |
| Previous close | $3.48 |
| Daily Range | $3.50 - $3.56 |
| 52-Week Range | $2.42 - $8.29 |
| Volume | 10,687 |


The fact that the FDA informed Biodelivery that a decision is close and an extension letter would not be needed is a positive sign, in my opinion. With the BDSI stock price slowly inching up over the past few months chances of an Onsolis approval are good.
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment